Online Testosterone Prescription — 2026 Comparison
Online TRT now covers the full delivery-route spectrum — injectable cypionate, transdermal cream, sublingual troche, and oral options like KYZATREX. The right choice depends on lifestyle, response, and clinician preference.
Testosterone replacement therapy is prescribed for men with clinically confirmed hypogonadism.
Men with documented low testosterone confirmed by lab testing and supportive symptoms.
Most providers require lab work upfront, and follow-up labs are typically required at the 8-12 week mark.
Rankings combine clinical formulary depth, pricing transparency, and shipping reliability — weighted equally and reviewed quarterly. Read the full methodology →
Providers That Prescribe online
Hormone optimisation platform with real biomarker testing and physician-guided protocols, for men and women.
Affordable subscription telehealth with one of the largest compounded formularies in the industry.
Affordable men's health clinic specialised in TRT and weight loss with transparent pricing.
Men's health clinic with TRT, a 4-in-1 liquid ED medication, and peptide therapies, shipped direct.
Online doctor's office and pharmacy with 48-hour delivery and no required virtual visit in most states.
Sermorelin-led peptide clinic that also covers GLP-1, NAD+, and brand-name Zepbound.
Compounded GLP-1 plus NAD+ and sermorelin longevity protocols under one membership.
Lab-driven telehealth clinic combining GLP-1, TRT, BHRT, and peptide longevity protocols.
Custom-compounded, rapid-dissolve treatments for men's health with transparent pricing and free provider visits.
What the Studies Actually Show
TRT is most strongly evidence-based when prescribed for clinically confirmed hypogonadism. The figures below come from the Endocrine Society and AUA guidelines and the TRAVERSE cardiovascular outcomes trial.
| Endpoint | Finding |
|---|---|
| Diagnostic threshold (Endocrine Society 2018)1 | Treatment is considered when total testosterone is consistently below ~264 ng/dL with consistent symptoms of hypogonadism |
| Cardiovascular safety (TRAVERSE, 5,246 men, ~33 months)2 | Testosterone replacement was non-inferior to placebo for major adverse cardiovascular events in middle-aged and older men with hypogonadism and elevated CV risk |
| Required safety monitoring (AUA 2018)3 | Hematocrit at baseline, 3–6 months, then annually; PSA at baseline and at follow-up testing in men age ≥40; lipids and CMP at baseline and 6–12 months |
| Hematocrit safety endpoint3 | Treatment paused if hematocrit exceeds 54% to reduce thrombotic risk |
| Fertility1 | Exogenous testosterone suppresses LH/FSH and spermatogenesis. Men interested in fertility should consider enclomiphene or hCG instead, or alongside, TRT |
- Endocrine Society Guideline — J Clin Endocrinol Metab 2018 · Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2018;103(5):1715–1744.
- TRAVERSE — NEJM 2023 · Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med 2023;389:107–117.
- AUA Guideline — J Urol 2018 · Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol 2018;200(2):423–432.
RxNotebook is an editorial publication. Citations point to peer-reviewed journals, FDA labeling, and clinical society guidelines. We are not affiliated with the studies cited above. This page is for general information and is not medical advice.